Represents percentage of acquisition of common stock.

No definition available.

Name:	blud_AcquiredCommonStockPercentage
Namespace Prefix:	blud_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Period of arrangement that could require the reporting entity to provide financial support.

+ References

No definition available.

+ Details

Name:	blud_VariableInterestEntityArrangementsTerm
Namespace Prefix:	blud_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The increase (decrease) during the reporting period in outstanding loans including accrued interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3602-108585

+ Details

Name:	us-gaap_IncreaseDecreaseInFinanceReceivables
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount after allowance and deduction of deferred interest and fees, unamortized costs and premiums and discounts from face amounts, of loans and leases held in portfolio, including but not limited to, commercial and consumer loans. Includes loans held for sale. Excludes loans and leases covered under loss sharing agreements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.7(a))
-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878

+ Details

Name:	us-gaap_LoansReceivableNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The cash outflow for derivative instruments during the period, which are classified as investing activities, excluding those designated as hedging instruments.

+ References

No definition available.

+ Details

Name:	us-gaap_PaymentsForDerivativeInstrumentInvestingActivities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph b
-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5728-111685

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 6
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=52262685&loc=d3e5747-111685

+ Details

Name:	us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

The amount of financial or other support the reporting entity has provided (explicitly or implicitly) to the Variable Interest Entity (VIE) that it was not previously contractually required to provide or that the reporting entity intends to provide, including, for example, situations in which the reporting entity assisted the VIE in obtaining another type of support.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=52262685&loc=SL6759159-111685

+ Details

Name:	us-gaap_VariableInterestEntityFinancialOrOtherSupportAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 5A
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=52262685&loc=SL6759159-111685

+ Details

Name:	us-gaap_VariableInterestEntityOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_DerivativeByNatureAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis=blud_SironaGenomicsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=blud_SironaGenomicsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Note 3 - Other Investments (Details Textual) - USD ($) $ in Millions		3 Months Ended	9 Months Ended
	Oct. 03, 2014	Feb. 29, 2016	Feb. 29, 2016	Mar. 04, 2016
Warrant [Member] \| Sirona Genomics Inc. [Member] \| Other Assets [Member]
Payments for Derivative Instrument, Investing Activities	$ 0.7		$ 0.7
Sirona Genomics Inc. [Member] \| Other Assets [Member]
Loans Receivable, Net	9.5	$ 9.5	9.5
Increase (Decrease) in Finance Receivables		1.8
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount		$ 12.0	$ 12.0
Sirona Genomics Inc. [Member] \| Maximum [Member]
Variable Interest Entity, Financial or Other Support, Amount	$ 1.8
Sirona Genomics Inc. [Member]
Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage	100.00%
Variable Interest Entity, Arrangements Term	2 years
Sirona Genomics Inc. [Member] \| Subsequent Event [Member]
Acquired Common Stock, Percentage				100.00%